中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2015年
13期
53-55
,共3页
α受体阻滞剂%前列腺电切%排尿状况
α受體阻滯劑%前列腺電切%排尿狀況
α수체조체제%전렬선전절%배뇨상황
Alpha blockers%Transurethral resection%Urination situation
目的：探讨选择性α1受体阻滞剂对经尿道前列腺汽化电切术后早期患者排尿状况的影响。方法：依据纳入排除标准共选取130例患者并按照电脑产生的随机数列分为两组，对照组给予常规治疗措施，研究组给予常规措施+选择性α受体阻滞剂进行治疗，比较两组患者术后最大尿流量、IPSS评分、临床不良反应。结果：研究组患者术后最大尿流量为（15.6±1.23）mL/s，IPSS评分为（7.35±3.34）分，均较对照组有明显改善，比较差异有统计学意义（P<0.05）。对照组治疗总不良反应为38.4%，高于研究组15.3%，比较差异有统计学意义（P<0.05）。结论：选择性α1受体阻滞剂对经尿道前列前腺汽化电切术后早期患者排尿状况的临床效果较佳，既可有效缩短患者的排尿时间，又可避免转为重症疾病等，显著提高治疗有效率，值得临床推广使用。
目的：探討選擇性α1受體阻滯劑對經尿道前列腺汽化電切術後早期患者排尿狀況的影響。方法：依據納入排除標準共選取130例患者併按照電腦產生的隨機數列分為兩組，對照組給予常規治療措施，研究組給予常規措施+選擇性α受體阻滯劑進行治療，比較兩組患者術後最大尿流量、IPSS評分、臨床不良反應。結果：研究組患者術後最大尿流量為（15.6±1.23）mL/s，IPSS評分為（7.35±3.34）分，均較對照組有明顯改善，比較差異有統計學意義（P<0.05）。對照組治療總不良反應為38.4%，高于研究組15.3%，比較差異有統計學意義（P<0.05）。結論：選擇性α1受體阻滯劑對經尿道前列前腺汽化電切術後早期患者排尿狀況的臨床效果較佳，既可有效縮短患者的排尿時間，又可避免轉為重癥疾病等，顯著提高治療有效率，值得臨床推廣使用。
목적：탐토선택성α1수체조체제대경뇨도전렬선기화전절술후조기환자배뇨상황적영향。방법：의거납입배제표준공선취130례환자병안조전뇌산생적수궤수렬분위량조，대조조급여상규치료조시，연구조급여상규조시+선택성α수체조체제진행치료，비교량조환자술후최대뇨류량、IPSS평분、림상불량반응。결과：연구조환자술후최대뇨류량위（15.6±1.23）mL/s，IPSS평분위（7.35±3.34）분，균교대조조유명현개선，비교차이유통계학의의（P<0.05）。대조조치료총불량반응위38.4%，고우연구조15.3%，비교차이유통계학의의（P<0.05）。결론：선택성α1수체조체제대경뇨도전렬전선기화전절술후조기환자배뇨상황적림상효과교가，기가유효축단환자적배뇨시간，우가피면전위중증질병등，현저제고치료유효솔，치득림상추엄사용。
Objective:To investigate the effect of selective alpha 1 adrenoceptor blockers on early urination of patients after transurethral electrovaporization of the prostate. Method:According to inclusion and exclusion criteria,130 patients were selected and randomly divided into two groups,control group was given conventional treatment measures, research group was treated with conventional measures and selective alpha blocker,compared two groups’ objective index case(postoperative maximum urine flow),(IPSS score)and the clinical adverse reaction. Result:There were maximal urinary flow in the research group patients after treatment,(15.6±1.23)mL/s,IPSS score of(7.35±3.34)was improved significantly than the control group,the difference was statistically significant(P<0.05). The control group’s total adverse reaction was 38.4%,which was higher than 15.3% of the research group,the difference was statistically significant (P<0.05). Conclusion:Selective alpha 1 adrenoceptor blocker has good clinical effect on early urination of patients after transurethral electrovaporization of the prostate it not only can effectively shorten the patients emiction time,but also avoidto severe disease,significantly improves the treatment efficiency,so it is worthy of clinical use.
